Return to list Nicole Ullrich, MD, PhD
Nicole Ullrich, MD, PhD
Associate Professor of Neurology, Harvard Medical School
Director, Neuro-oncology and NF Clinical Trials Program; Associate Director, NF Program, Boston Children’s Hospital
Boston Children's Hospital
333 Longwood Avenue
Boston, MA 02115
Dr. Ullrich’s primary focus is on her research for the Neurofibromatosis Clinical Trials Consortium at Children’s Hospital Boston, one of nine sites in the United States funded by the Department of Defense. The goal of the Consortium is to develop novel therapies for patients with neurofibromatosis type 1 (NF1), and Dr. Ullrich serves as the Site PI for three clinical trials currently taking place.
The first is a Phase II clinical trial of rapamycin for progressive plexiform neurofibromas. The second, Lovastatin for Learning Deficits in Children with NF1, is a randomized clinical trial of lovastatin to reverse attention and spatial working memory deficits in children with NF1. The third is a randomized Phase II clinical trial of RAD001 (Everolimus) to treat chemotherapy-refractory brain tumors in children with NF1.
- Neurofibromatosis Clinical Trials Consortium - W81XWH-12-1-0155